Guardian Pharmacy Services, Inc. GRDN
We take great care to ensure that the data presented and summarized in this overview for Guardian Pharmacy Services, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in GRDN
Top Purchases
Top Sells
About GRDN
Insider Transactions at GRDN
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 04
2025
|
Kendall Forbes |
SELL
Bona fide gift
|
Direct |
21,500
-2.65%
|
-
|
|
Dec 04
2025
|
Fred Burke |
SELL
Bona fide gift
|
Direct |
200,000
-11.68%
|
-
|
|
Dec 03
2025
|
Steven D Cosler |
BUY
Open market or private purchase
|
Direct |
3,370
+11.89%
|
$97,730
$29.61 P/Share
|
|
Sep 27
2025
|
Fred Burke |
BUY
Exercise of conversion of derivative security
|
Direct |
1,298,826
+43.14%
|
-
|
|
Sep 27
2025
|
Pharmacy Investors, LLC |
BUY
Exercise of conversion of derivative security
|
Direct |
1,413,940
+43.14%
|
-
|
|
Sep 27
2025
|
William E Bindley |
BUY
Exercise of conversion of derivative security
|
Indirect |
6,100,176
+43.14%
|
-
|
|
Sep 27
2025
|
David K Morris |
BUY
Exercise of conversion of derivative security
|
Direct |
641,869
+42.84%
|
-
|
|
Sep 27
2025
|
Thomas J Salentine Jr |
BUY
Exercise of conversion of derivative security
|
Indirect |
6,100,176
+43.14%
|
-
|
|
Sep 27
2025
|
Bindley Capital Partners I, LLC |
BUY
Exercise of conversion of derivative security
|
Direct |
6,100,176
+43.14%
|
-
|
|
Sep 27
2025
|
Cardinal Equity Fund, L.P. |
BUY
Exercise of conversion of derivative security
|
Direct |
471,057
+43.14%
|
-
|
|
Sep 27
2025
|
Kendall Forbes |
BUY
Exercise of conversion of derivative security
|
Direct |
608,570
+42.83%
|
-
|
|
Sep 27
2025
|
John Ackerman |
BUY
Exercise of conversion of derivative security
|
Indirect |
1,884,997
+43.14%
|
-
|
|
May 28
2025
|
Pharmacy Investors, LLC |
SELL
Open market or private sale
|
Direct |
150,998
-25.14%
|
$3,019,960
$20.16 P/Share
|
|
May 28
2025
|
Cardinal Equity Fund, L.P. |
SELL
Open market or private sale
|
Direct |
50,305
-25.14%
|
$1,006,100
$20.16 P/Share
|
|
May 28
2025
|
Kendall Forbes |
SELL
Open market or private sale
|
Direct |
64,991
-24.17%
|
$1,299,820
$20.16 P/Share
|
|
May 28
2025
|
Fred Burke |
SELL
Open market or private sale
|
Direct |
138,705
-25.14%
|
$2,774,100
$20.16 P/Share
|
|
May 28
2025
|
David K Morris |
SELL
Open market or private sale
|
Direct |
68,547
-24.22%
|
$1,370,940
$20.16 P/Share
|
|
May 28
2025
|
John Ackerman |
SELL
Open market or private sale
|
Indirect |
201,303
-25.14%
|
$4,026,060
$20.16 P/Share
|
|
May 28
2025
|
Thomas J Salentine Jr |
SELL
Open market or private sale
|
Indirect |
651,454
-25.14%
|
$13,029,080
$20.16 P/Share
|
|
May 28
2025
|
William E Bindley |
SELL
Open market or private sale
|
Indirect |
651,454
-25.14%
|
$13,029,080
$20.16 P/Share
|
Last 12 Months Summary
Buy / Acquisition
41.3M
Shares
From
15
Insiders
| Grant, award, or other acquisition | 32.5K shares |
|---|---|
| Open market or private purchase | 3.37K shares |
| Exercise of conversion of derivative security | 41.3M shares |
Sell / Disposition
17M
Shares
From
11
Insiders
| Open market or private sale | 16.8M shares |
|---|---|
| Bona fide gift | 222K shares |